XTX Topco’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,794
Closed -$463K 4466
2025
Q4
$463K Sell
3,794
-4,489
-54% -$515K 0.01% 1676
2025
Q3
$830K Sell
8,283
-62,136
-88% -$5.6M 0.04% 692
2025
Q2
$5.84M Buy
+70,419
New +$5.62M 0.24% 52

Other funds holding XBI

XTX Topco's XBI Position: Q1 2026 in Review

XTX Topco sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2026, closing a stake of 3,794 shares — an estimated $463K sold.

XTX Topco first reported a position in XBI in Q2 2025 and held it in 3 quarters. The position peaked at $5.84M in Q2 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • XTX Topco reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 3,794 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $463K.
  • XTX Topco first reported a position in State Street SPDR S&P Biotech ETF in Q2 2025 and held it in 3 quarters.
  • XTX Topco's State Street SPDR S&P Biotech ETF position peaked at $5.84M in Q2 2025.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.